These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 14004620)

  • 21. Transcriptional profiling of a mice plague model: insights into interaction between Yersinia pestis and its host.
    Liu H; Wang H; Qiu J; Wang X; Guo Z; Qiu Y; Zhou D; Han Y; Du Z; Li C; Song Y; Yang R
    J Basic Microbiol; 2009 Feb; 49(1):92-9. PubMed ID: 18759226
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pasteurella pestis of low virulence for mice and guinea pigs isolated from a Peromyscus plague focus in Utah.
    MARCHETTE NJ
    Am J Trop Med Hyg; 1963 Mar; 12():215-8. PubMed ID: 13932840
    [No Abstract]   [Full Text] [Related]  

  • 23. A hemagglutination test for plague antibody with purified capsular antigen of Pasteurella pestis.
    LANDY M; TRAPANI RJ
    Am J Hyg; 1954 Mar; 59(2):150-6. PubMed ID: 13138581
    [No Abstract]   [Full Text] [Related]  

  • 24. Stat 4 but not Stat 6 mediated immune mechanisms are essential in protection against plague.
    Elvin SJ; Williamson ED
    Microb Pathog; 2004 Oct; 37(4):177-84. PubMed ID: 15458778
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Yersinia pestis Yop secretion protein F: purification, characterization, and protective efficacy against bubonic plague.
    Swietnicki W; Powell BS; Goodin J
    Protein Expr Purif; 2005 Jul; 42(1):166-72. PubMed ID: 15939303
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Small protective fragments of the Yersinia pestis V antigen.
    Vernazza C; Lingard B; Flick-Smith HC; Baillie LW; Hill J; Atkins HS
    Vaccine; 2009 May; 27(21):2775-80. PubMed ID: 19366573
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The immune response of the guinea pig to the antigens of Pasteurella pestis.
    SPIVACK ML; FOSTER L; LARSON A; CHEN TH; BAKER EE; MEYER KF
    J Immunol; 1958 Feb; 80(2):132-41. PubMed ID: 13514082
    [No Abstract]   [Full Text] [Related]  

  • 28. VIRULENCE OF PASTEURELLA PESTIS AND IMMUNITY TO PLAGUE.
    BURROWS TW
    Ergeb Mikrobiol Immunitatsforsch Exp Ther; 1963; 37():59-113. PubMed ID: 14324291
    [No Abstract]   [Full Text] [Related]  

  • 29. Anti-Pasteurella pestis factor from mice and guinea pigs. II. Some chemical and physical characteristics.
    Eisler DM; Hill B; Von Metz EK; Chang WJ; Heckly RJ
    J Immunol; 1967 Mar; 98(3):576-83. PubMed ID: 6020580
    [No Abstract]   [Full Text] [Related]  

  • 30. Pneumonic plague in mice: modification of the infection by antibody against specific components of Pasteurella pestis.
    SMITH PN
    J Infect Dis; 1959; 104(1):85-91. PubMed ID: 13631291
    [No Abstract]   [Full Text] [Related]  

  • 31. Protection against plague afforded by immunisation with DNA vaccines optimised for expression of the Yersinia pestis V antigen.
    Garmory HS; Freeman D; Brown KA; Titball RW
    Vaccine; 2004 Feb; 22(8):947-57. PubMed ID: 15161071
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Influence of guinea pig plasma factors on phagocytosis of Pasteurella pestis. I. Plasma from normal guinea pigs.
    STANZIALE WG; WHITE JD
    J Bacteriol; 1962 Jan; 83(1):175-81. PubMed ID: 13916283
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Response of guinea pig lungs to in vivo and in vitro cultures of Pasteurella pestis.
    FUKUI GM; LAWTON WD; JANSSEN WA; SURGALLA MJ
    J Infect Dis; 1957; 100(1):103-7. PubMed ID: 13416642
    [No Abstract]   [Full Text] [Related]  

  • 34. [On the problem of the nature of a fibrinolytic substance in plague microbes].
    IAROMIUK GA; DOMARADSKII IV
    Biull Eksp Biol Med; 1962 Apr; 53():87-91. PubMed ID: 14450449
    [No Abstract]   [Full Text] [Related]  

  • 35. Immunogenicity of the rF1+rV vaccine for plague with identification of potential immune correlates.
    Williamson ED; Flick-Smith HC; Waters E; Miller J; Hodgson I; Le Butt CS; Hill J
    Microb Pathog; 2007 Jan; 42(1):11-21. PubMed ID: 17107769
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Role of the capsule of Pasteurella pestis in bubonic plague in the guinea pig.
    DONAVAN JE; HAM D; FUKUI GM; SURGALLA MJ
    J Infect Dis; 1961; 109():154-7. PubMed ID: 13887192
    [No Abstract]   [Full Text] [Related]  

  • 37. Studies on immunization against plague. VI. Growth of pasteurella pestis and the production of the envelope and other soluble antigens in a casein hydrolyzate mineral glucose medium.
    ENGELSBERG E; LEVY JB
    J Bacteriol; 1954 Apr; 67(4):438-49. PubMed ID: 13152055
    [No Abstract]   [Full Text] [Related]  

  • 38. [The effect of streptomycin therapy on the pathogenic action of Pasteurella pestis in experimentally induced pneumonic plague in guinea pigs].
    NEEL R
    Bull Soc Pathol Exot Filiales; 1951; 44(1-2):69-76. PubMed ID: 14830980
    [No Abstract]   [Full Text] [Related]  

  • 39. Use of the antiserum-agar plate technique for specific identification and isolation of Pasteurella pestis.
    Albizo JM; Surgalla MJ
    Appl Microbiol; 1968 Aug; 16(8):1114-9. PubMed ID: 4877497
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Molecular detection of Yersinia pestis isolates of Indian origin by using Pla specific monoclonal antibodies.
    Mahesh S; Shukla J; Tuteja U; Batra HV
    Comp Immunol Microbiol Infect Dis; 2005 Mar; 28(2):131-44. PubMed ID: 15582689
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.